Inna Y. Gong

Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy

Inna Y. Gong, Rommel G. Tirona, Ute I. Schwarz et al. · Blood · 2011 · 94 citations

Fatal Hydrocodone Overdose in a Child: Pharmacogenetics and Drug Interactions

Parvaz Madadi, Doris Hildebrandt, Inna Y. Gong et al. · PEDIATRICS · 2010 · 94 citations

Pharmacotherapy, Cytochrome P450 2D6, Drug Resistance +22

Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response

Inna Y. Gong, Natalie Crown, Colin Suen et al. · European Heart Journal · 2012 · 83 citations

CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy

Wendy A. Teft, Inna Y. Gong, B. Dingle et al. · Breast Cancer Research and Treatment · 2013 · 77 citations

Medicine, Tamoxifen Therapy, Vitamin D Status +4

Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation

Inna Y. Gong, Ute I. Schwarz, Natalie Crown et al. · PLoS ONE · 2011 · 72 citations · Full text